Cargando…

Contemporary National Patterns of Eligibility and Use of Novel Lipid‐Lowering Therapies in the United States

BACKGROUND: The emergence of PCSK9i (proprotein convertase subtilisin kexin type 9 inhibitor) and icosapent ethyl (IPE) has expanded the role of lipid‐lowering therapies beyond statins. Despite recommendations by clinical practice guidelines, their national eligibility and use rates remain unclear....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Miles, Aghajani Nargesi, Arash, Nasir, Khurram, Bhatt, Deepak L., Khera, Rohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683659/ https://www.ncbi.nlm.nih.gov/pubmed/36102276 http://dx.doi.org/10.1161/JAHA.122.026075

Ejemplares similares

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
por: Nargesi, Arash A., et al.
Publicado: (2021)

Impact of 2017 ACC/AHA guidelines on prevalence of hypertension and eligibility for antihypertensive treatment in United States and China: nationally representative cross sectional study
por: Khera, Rohan, et al.
Publicado: (2018)

Use of Wearable Devices in Individuals With or at Risk for Cardiovascular Disease in the US, 2019 to 2020
por: Dhingra, Lovedeep S., et al.
Publicado: (2023)

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions
por: Khera, Rohan, et al.
Publicado: (2020)

Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges
por: Aghajani Nargesi, Arash, et al.
Publicado: (2017)

Lipid Lowering Treatment and Eligibility for PCSK9 Inhibition in Post-Myocardial Infarction Patients in Italy: Insights from Two Contemporary Nationwide Registries
por: Colivicchi, Furio, et al.
Publicado: (2020)

Appearance of leptin–HSP70 correlation, in type 2 diabetes()
por: Nakhjavani, Manouchehr, et al.
Publicado: (2013)

County-level variation in cardioprotective antihyperglycemic prescribing among medicare beneficiaries
por: Hanna, Jonathan, et al.
Publicado: (2022)

Metabolic syndrome in premenopausal and postmenopausal women with type 2 diabetes: loss of protective effects of premenopausal status
por: Nakhjavani, Manouchehr, et al.
Publicado: (2014)

Out‐of‐Pocket Annual Health Expenditures and Financial Toxicity From Healthcare Costs in Patients With Heart Failure in the United States
por: Wang, Stephen Y., et al.
Publicado: (2021)

Can Contemporary Patients with Biopsy Gleason Score 3+4 Be Eligible for Active Surveillance?
por: Kwon, Ohseong, et al.
Publicado: (2014)

Non‐ST‐Elevation Myocardial Infarction in the United States: Contemporary Trends in Incidence, Utilization of the Early Invasive Strategy, and In‐Hospital Outcomes
por: Khera, Sahil, et al.
Publicado: (2014)

Contemporary analysis of epididymal tumors using a national database
por: Bhatt, Rohit, et al.
Publicado: (2021)

Remifentanil versus Propofol/Fentanyl Combination in Procedural Sedation for Dislocated Shoulder Reduction; a Clinical Trial
por: Monsef Kasmaee, Vahid, et al.
Publicado: (2019)

Renal Artery Stenosis Alters Gene Expression in Swine Scattered Tubular-Like Cells
por: Aghajani Nargesi, Arash, et al.
Publicado: (2019)

Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non‐Elderly Adults in the United States
por: Mszar, Reed, et al.
Publicado: (2020)

Performance of the Pooled Cohort Equations in Hispanic Individuals Across the United States: Insights From the Multi‐Ethnic Study of Atherosclerosis and the Dallas Heart Study
por: Flores Rosario, Karen, et al.
Publicado: (2021)

Generalizability of FIGARO‐DKD and FIDELIO‐DKD Trial Criteria to the US Population Eligible for Finerenone
por: Chiu, Nicholas, et al.
Publicado: (2022)

Patterns of Medicaid Eligibility: A Sample of 408 Medi-Cal Eligibles in San Francisco, California
por: Celum, Connie L., et al.
Publicado: (1981)

Lung Cancer Screening Eligibility and Screening Patterns Among Black and White Adults in the United States
por: Lozier, Jessica W., et al.
Publicado: (2021)

Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2019)

Measures of Financial Hardship From Health Care Expenses Among Families With a Member With Atherosclerotic Cardiovascular Disease in the US
por: Wang, Stephen Y., et al.
Publicado: (2022)

Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States
por: Mahajan, Shiwani, et al.
Publicado: (2021)

Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases
por: Choi, Su-Yeon, et al.
Publicado: (2020)

Pregnancy Outcome Patterns of Medicaid-Eligible Women, 1999-2014: A National Prospective Longitudinal Study
por: Studnicki, James, et al.
Publicado: (2020)

Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
por: Vikulova, Diana N., et al.
Publicado: (2020)

Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States
por: Valero-Elizondo, Javier, et al.
Publicado: (2021)

Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi‐Ethnic Study of Atherosclerosis)
por: Miedema, Michael D., et al.
Publicado: (2018)

Absence of a positive correlation between CRP and leptin in rheumatoid arthritis
por: Najafizadeh, Seyed Reza, et al.
Publicado: (2016)

Preferences of Iranians to select the emergency department physician at the time of service delivery
por: Nargesi, Dorrin Aghajani, et al.
Publicado: (2021)

Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy
por: Begovac, Josip, et al.
Publicado: (2015)

Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease
por: Peterson, Benjamin E., et al.
Publicado: (2023)

Post-discharge acute care and outcomes following readmission reduction initiatives: national retrospective cohort study of Medicare beneficiaries in the United States
por: Khera, Rohan, et al.
Publicado: (2020)

Contemporary Practice Patterns for the Treatment of Anterior Cruciate Ligament Tears in the United States
por: Cevallos, Nicolas, et al.
Publicado: (2021)

Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives
por: De Luca, Leonardo, et al.
Publicado: (2021)

Patient Eligibility for Transoral Endocrine Surgery Procedures in the United States
por: Grogan, Raymon H., et al.
Publicado: (2019)

Meta-Analysis of Contemporary Trials of Omega-3 Fatty Acids Containing Both Eicosapentaenoic and Docosahexaenoic Acids
por: Khan, Safi U., et al.
Publicado: (2021)

Contemporary diagnosis of lower urinary tract dysfunction.
por: Rosier, Peter
Publicado: (2019)

Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Khan, Safi U., et al.
Publicado: (2019)

Diagnostic Accuracy of Contemporary Selection Criteria in Prostate Cancer Patients Eligible for Active Surveillance: A Bayesian Network Meta-Analysis
por: Fan, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1kk5u57jkrv3rinll4t67d3h2c